ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,855.59
-0.08%
Gold vs US Dollar
2,295.57
-3.42%
Brent Oil
79.255
-0.78%
Bitcoin
69,224.99
-2.17%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Cerevel Therapeutics Holdings Inc (CERE) Share Price

CERE Cerevel Therapeutics Holdings Inc

39.965
-0.295 (-0.73%)
Last Updated: 20:22:09
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Cerevel Therapeutics Holdings Inc NASDAQ:CERE NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.295 -0.73 39.965 39.96 39.97 40.625 39.96 40.22 508,454 19:22:09   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -432.84M -2.3838 -4.24 1.83B
 Type  Size  Price  Time  Units 
  100 39.965 19:22:09 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore CERE News
08/05/202421:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
18/04/202411:30GLOBECerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease
27/02/202421:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
16/02/202421:46EDGAR2Form 8-K - Current report
09/02/202414:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09/02/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
24/01/202413:30PRNUSKuehn Law Encourages MDC, WAVD, NS and CERE Investors to Contact Law Firm
Period
Draw mode
Data Downloads for CERE

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Cerevel Therapeutics Holdings Inc Articles